Theranostics meets traditional Chinese medicine: rational prediction of drug–herb interactions

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Review of Molecular Diagnostics

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/erm.12.126PMID 23249200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice.

  2012cited by this paper
• An Overview of the Evidence and Mechanisms of Herb–Drug Interactions

  2012cited by this paper
• Drug Interactions with Herbal Medicines

  2012cited by this paper
• Herbal remedies affecting coagulation: A review

  2012cited by this paper
• Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions.

  2012cited by this paper
• Anticoagulant activity of select dietary supplements.

  2012cited by this paper
• Herb-drug interactions: methods to identify potential influence of genetic variations in genes encoding drug metabolizing enzymes and drug transporters.

  2012cited by this paper
• Herb-drug interactions and mechanistic and clinical considerations.

  2012cited by this paper
• Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data

  2012cited by this paper
• Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo.

  2012cited by this paper
• Interactions Between Herbal Medicines and Prescribed Drugs

  2012cited by this paper
• Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines.

  2011cited by this paper
• Effect of Herbal Consumption on Time in Therapeutic Range of Warfarin Therapy in Patients With Atrial Fibrillation

  2011cited by this paper
• Herb-drug interactions: Focus on metabolic enzymes and transporters

  2011cited by this paper
• Risk of Hemorrhage Associated with Co-Prescriptions for Ginkgo biloba and Antiplatelet or Anticoagulant Drugs

  2011cited by this paper
• Induction of expression and functional activity of P-glycoprotein efflux transporter by bioactive plant natural products.

  2011cited by this paper
• Pregnane X receptor-mediated induction of Cyp3a by black cohosh

  2011cited by this paper
• Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.

  2011cited by this paper
• Identification of novel pregnane X receptor activators from traditional Chinese medicines.

  2011cited by this paper
• Herb-drug interactions involving drug metabolizing enzymes and transporters.

  2011cited by this paper
• Is There a Risk of Bleeding Associated with Standardized Ginkgo bilobaExtract Therapy? A Systematic Review and Meta‐analysis

  2011cited by this paper
• The Pregnane X Receptor Agonist St John’s Wort Has No Effects on the Pharmacokinetics and Pharmacodynamics of Repaglinide

  2011cited by this paper
• Inhibitory Effects of Commonly Used Herbal Extracts on UDP-Glucuronosyltransferase 1A4, 1A6, and 1A9 Enzyme Activities

  2011cited by this paper
• Clinical herbal interactions with conventional drugs: from molecules to maladies.

  2011cited by this paper
• Epigenetics in Traditional Chinese Pharmacy: A Bioinformatic Study at Pharmacopoeia Scale

  2011cited by this paper
• Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective

  2011cited by this paper
• Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions

  2011cited by this paper
• Evaluation of metabolism-mediated herb-drug interactions

  2011cited by this paper
• Drug interactions with St. John's wort products.

  2011cited by this paper
• Effect of Wuzhi Tablet (Schisandra sphenanthera extract) on the Pharmacokinetics of Paclitaxel in Rats

  2011cited by this paper
• Pharmacokinetic profiles of anticancer herbal medicines in humans and the clinical implications.

  2011cited by this paper
• Botanicals as medicinal food and their effects on drug metabolizing enzymes.

  2011cited by this paper
• Clinically-relevant chemotherapy interactions with complementary and alternative medicines in patients with cancer

  2010cited by this paper
• Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail

  2010cited by this paper
• Inhibition of Intestinal and Hepatic Glucuronidation of Mycophenolic Acid by Ginkgo biloba Extract and Flavonoids

  2010cited by this paper
• Effects of Herbal Supplements on Drug Glucuronidation. Review of Clinical, Animal, and In Vitro Studies

  2010cited by this paper
• Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.

  2010cited by this paper
• Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1.

  2010cited by this paper
• P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions

  2010cited by this paper
• Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment.

  2010cited by this paper
• Use of herbal products and potential interactions in patients with cardiovascular diseases.

  2010cited by this paper
• Antithrombotic effects of naturally derived products on coagulation and platelet function.

  2010cited by this paper
• Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients

  2010cited by this paper
• Echinacea purpurea Significantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir‐Ritonavir Exposure in Healthy Subjects

  2010cited by this paper
• Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

  2010cited by this paper
• Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro.

  2010cited by this paper
• Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity

  2010cited by this paper
• Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506).

  2010cited by this paper
• Clinically-relevant chemotherapy interactions with complementary and alternative medicines in patients with cancer.

  2010cited by this paper
• Herb–drug pharmacokinetic interactions reviewed

  2010cited by this paper
• Grapefruit Juice Greatly Reduces the Plasma Concentrations of the OATP2B1 and CYP3A4 Substrate Aliskiren

  2010cited by this paper
• Evidence-based management of herb-drug interaction in cancer chemotherapy.

  2010cited by this paper
• Effects of herbal products on the metabolism and transport of anticancer agents

  2010cited by this paper
• Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans.

  2010cited by this paper
• Importance of providing cardiologists with useful advice on herb-drug interactions.

  2010cited by this paper
• Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions

  2010cited by this paper
• Drug-drug interactions of silymarin on the perspective of pharmacokinetics.

  2009cited by this paper
• Induction of chemoprotective phase 2 enzymes by ginseng and its components.

  2009cited by this paper
• Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo.

  2009cited by this paper
• Inhibition of Human CYP2B6-Catalyzed Bupropion Hydroxylation by Ginkgo biloba Extract: Effect of Terpene Trilactones and Flavonols

  2009cited by this paper
• Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers

  2009cited by this paper
• Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.

  2009cited by this paper
• Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation

  2009cited by this paper
• Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem

  2009cited by this paper
• Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives.

  2009cited by this paper
• Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers

  2009cited by this paper
• Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations

  2009cited by this paper
• Bioactive Terpenoids and Flavonoids from Ginkgo Biloba Extract Induce the Expression of Hepatic Drug-Metabolizing Enzymes Through Pregnane X Receptor, Constitutive Androstane Receptor, and Aryl hydrocarbon Receptor-Mediated Pathways

  2009cited by this paper
• Effects of Ginkgo biloba Extract Ingestion on the Pharmacokinetics of Talinolol in Healthy Chinese Volunteers

  2009cited by this paper
• Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.

  2008cited by this paper
• The Traditional Chinese Herbal Remedy Tian Xian Activates Pregnane X Receptor and Induces CYP3A Gene Expression in Hepatocytes

  2008cited by this paper
• Inhibitory Effects of Seven Components of Danshen Extract on Catalytic Activity of Cytochrome P450 Enzyme in Human Liver Microsomes

  2008cited by this paper
• Review Article: Cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: Grapefruit juice, St John's Wort – and beyond! (Review Article)

  2008cited by this paper
• Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study.

  2008cited by this paper
• Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius

  2008cited by this paper
• Herbal and dietary supplement--drug interactions in patients with chronic illnesses.

  2008cited by this paper
• The effect of green tea on simvastatin tolerability.

  2008cited by this paper
• Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects

  2008cited by this paper
• Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration.

  2008cited by this paper
• Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies.

  2008cited by this paper
• The Effect of Herbal Medicine Baicalin on Pharmacokinetics of Rosuvastatin, Substrate of Organic Anion‐transporting Polypeptide 1B1

  2008cited by this paper
• In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?

  2008cited by this paper
• Inhibition and induction of human cytochrome P450 enzymes: current status

  2008cited by this paper
• In Vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes

  2008cited by this paper
• Molecular mechanisms underlying St. John's wort drug interactions.

  2008cited by this paper
• Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide

  2008cited by this paper
• Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs.

  2008cited by this paper
• Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

  2007cited by this paper
• Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine.

  2007cited by this paper
• Induction of Intestinal P‐glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol

  2007cited by this paper
• Bilobalide in ginkgo biloba extract is a major substance inducing hepatic CYPs

  2007cited by this paper
• Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.

  2007cited by this paper
• Medicinal importance of grapefruit juice and its interaction with various drugs

  2007cited by this paper
• Intestinal and hepatic glucuronidation of flavonoids.

  2007cited by this paper
• Interaction between a commercially available St. John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia

  2007cited by this paper
• Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.

  2007cited by this paper
• EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

  2006cited by this paper
• Interaction Between Warfarin and Cranberry Juice

  2006cited by this paper
• In vitro and in vivo assessment of herb drug interactions.

  2006cited by this paper
• Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole

  2006cited by this paper

• Interactions of antidepressants with concomitant medications—safety of complex therapies in multimorbidities

  2024cites this paper
• Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment

  2021cites this paper
• Determination of benchmark doses for linear furanocoumarin consumption associated with inhibition of cytochrome P450 1A2 isoenzyme activity in healthy human adults

  2021cites this paper
• Current Role of Herbal and Natural Preparations.

  2019cites this paper
• Clinical Perspectives in Diagnostic-omics and Personalized Medicine Approach to Monitor Effectiveness and Toxicity of Phytocomplexes

  2017cites this paper
• Effects of crude and vinegar-processed Curcumae Rhizoma on the activities of CYP 450 enzymes in rats

  2017cites this paper
• Utilization of Chinese Herbal Medicine for Selected Oral Conditions in Two Pediatric Populations.

  2016cites this paper
• Inhibition of Caffeine Metabolism in Humans by Furanocoumarin-Containing Plant Extracts: In Vivo and In Vitro Studies

  2016cites this paper
• Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition

  2015cites this paper
• Development of in Silico Models for Predicting P-Glycoprotein Inhibitors Based on a Two-Step Approach for Feature Selection and Its Application to Chinese Herbal Medicine Screening.

  2015cites this paper
• Progress on the Interaction Between Herb Medicine and Anti-HIV Chemical Drugs

  2015cites this paper
• The Classification and Application of Toxic Chinese Materia Medica

  2014cites this paper
• Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7.

  2014cites this paper
• Role of pregnane X receptor in chemotherapeutic treatment

  2014cites this paper
• The inhibitory effects of the ethanolic extract of Pimpinella brachycarpa on cytochrome P450 enzymes in humans

  2014cites this paper
• Theranostics: rethinking postgenomic diagnostics

  2012cites this paper
• Theranostics involves a variety of biotechnological inventions including the data-intensive platforms ( genomics , proteomics and metabolomics ) nanotechnology and hybrid assay platforms as exemplified by nanoproteomics

  2012cites this paper
• Mini FOCUS y Theranostics for innovation in 21st Century Healthcare

  2012cites this paper